Literature DB >> 15991228

Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness?

Anne Louise Oaklander1, Bradley R Buchbinder.   

Abstract

A postherpetic-neuralgia patient abruptly discontinued pregabalin. Thirty hours later, unexplained nausea, headache, and ataxia developed, progressing to delirium 8 days later. Magnetic resonance imaging indicated T2-hyperintense lesions of her splenium. Similar magnetic resonance imaging abnormalities, interpreted as focal vasogenic edema, develop in some epileptic patients after rapid anticonvulsant withdrawal. Patients with high-altitude cerebral edema have similar splenial-predominant magnetic resonance imaging abnormalities that accompany these same neurological symptoms. This case is the first to associate anticonvulsant-withdrawal splenial abnormalities with neurological symptoms, with gabapentin-type anticonvulsants, and is among the first in nonepileptic patients, suggesting that sudden anticonvulsant withdrawal alone, unaccompanied by seizures, can initiate symptomatic focal brain edema. The similarity of this syndrome to high-altitude cerebral edema suggests a possible common pathophysiology and offers potential therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991228     DOI: 10.1002/ana.20583

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Authors:  Cory Toth
Journal:  Ther Adv Drug Saf       Date:  2014-02

Review 2.  Diabetic painful neuropathy: current and future treatment options.

Authors:  M Sam Chong; Joan Hester
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis.

Authors:  M Nelles; C G Bien; M Kurthen; M von Falkenhausen; H Urbach
Journal:  Neuroradiology       Date:  2006-05-04       Impact factor: 2.804

Review 4.  Pregabalin for neuropathic pain based on recent clinical trials.

Authors:  Brett R Stacey; Jon N Swift
Journal:  Curr Pain Headache Rep       Date:  2006-06

Review 5.  Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.

Authors:  Robert W Johnson; Gunnar Wasner; Patricia Saddier; Ralf Baron
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.

Authors:  Pei-Lin Lu; John F Hodes; Xu Zheng; Xing-Yue Hu
Journal:  Intern Med       Date:  2020-06-30       Impact factor: 1.271

7.  Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis.

Authors:  Nida Tascilar; Hande Aydemir; Ufuk Emre; Aysun Unal; H Tugrul Atasoy; Sureyya Ekem
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

8.  Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.

Authors:  Hayahito Ishikawa; Masahiro Takeshima; Hiroyasu Ishikawa; Naoko Ayabe; Hidenobu Ohta; Kazuo Mishima
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.